| Year |
Citation |
Score |
| 2024 |
Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Bertucci F, et al. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 4: 236. PMID 38282551 DOI: 10.1158/2767-9764.CRC-24-0046 |
0.682 |
|
| 2023 |
Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Shen Y, et al. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications. 3: 1078-1092. PMID 37377604 DOI: 10.1158/2767-9764.CRC-22-0330 |
0.679 |
|
| 2019 |
Perry NA, Fialkowski KP, Kaoud TS, Kaya AI, Chen AL, Taliaferro JM, Gurevich VV, Dalby KN, Iverson TM. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase. Cellular Signalling. 109366. PMID 31352007 DOI: 10.1016/J.Cellsig.2019.109366 |
0.767 |
|
| 2019 |
Harger M, Lee JH, Walker B, Taliaferro JM, Edupuganti R, Dalby KN, Ren P. Computational insights into the binding of IN17 inhibitors to MELK. Journal of Molecular Modeling. 25: 151. PMID 31069524 DOI: 10.1007/S00894-019-4036-1 |
0.739 |
|
| 2017 |
Pitner MK, Taliaferro JM, Dalby KN, Bartholomeusz C. MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. Expert Opinion On Therapeutic Targets. 1-11. PMID 28764577 DOI: 10.1080/14728222.2017.1363183 |
0.623 |
|
| 2017 |
Edupuganti R, Taliaferro JM, Wang Q, Xie X, Cho EJ, Vidhu F, Ren P, Anslyn EV, Bartholomeusz C, Dalby KN. Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth. Bioorganic & Medicinal Chemistry. PMID 28351607 DOI: 10.1016/J.Bmc.2017.03.018 |
0.791 |
|
| 2016 |
Robinson MR, Taliaferro JM, Dalby KN, Brodbelt JS. 193 nm Ultraviolet Photodissociation Mass Spectrometry for Phosphopeptide Characterization in the Positive and Negative Ion Modes. Journal of Proteome Research. PMID 27425180 DOI: 10.1021/Acs.Jproteome.6B00289 |
0.452 |
|
| 2013 |
Taliaferro JM, Marwha D, Aspden JL, Mavrici D, Cheng NE, Kohlstaedt LA, Rio DC. The Drosophila splicing factor PSI is phosphorylated by casein kinase II and tousled-like kinase. Plos One. 8: e56401. PMID 23437125 DOI: 10.1371/Journal.Pone.0056401 |
0.336 |
|
| 2012 |
Kaoud TS, Yan C, Mitra S, Tseng CC, Jose J, Taliaferro JM, Tuohetahuntila M, Devkota A, Sammons R, Park J, Park H, Shi Y, Hong J, Ren P, Dalby KN. From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules. Acs Medicinal Chemistry Letters. 3: 721-725. PMID 23002419 DOI: 10.1021/Ml300129B |
0.698 |
|
| 2012 |
Kaoud TS, Park H, Mitra S, Yan C, Tseng CC, Shi Y, Jose J, Taliaferro JM, Lee K, Ren P, Hong J, Dalby KN. Manipulating JNK signaling with (--)-zuonin A. Acs Chemical Biology. 7: 1873-83. PMID 22916726 DOI: 10.1021/Cb300261E |
0.779 |
|
| 2012 |
Kaoud TS, Yan C, Tseng C, Jose J, Devkota AK, Taliaferro J, Ren P, Dalby K. Abstract 4776: From in-silico screening to anti-cancer activity: The discovery of a potent inhibitor targeting the JNK-JIP interaction Cancer Research. 72: 4776-4776. DOI: 10.1158/1538-7445.Am2012-4776 |
0.769 |
|
| 2011 |
Kaoud TS, Mitra S, Lee S, Taliaferro J, Cantrell M, Linse KD, Van Den Berg CL, Dalby KN. Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration. Acs Chemical Biology. 6: 658-66. PMID 21438496 DOI: 10.1021/Cb200017N |
0.741 |
|
| Show low-probability matches. |